SEARCH

SEARCH BY CITATION

References

  • Böck, M., de Haan, J., Beck, K-H., Gutensohn, K., Hertfelder, H-J., Karger, R., Heim, M.U., Beeser, H., Weber, D. & Kretschmer, V. (1999) Standardization of the PFA-100® platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives. British Journal of Haematology, 106, 898904.
  • Golanski, J, Pluta, J., Baraniak, J. & Datala, C. (2004) Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists – in vitro experience. Clinical Chemical Laboratory Medicine, 42, 2529.
  • Haubelt, H., Anders, C., Vogt, A., Hoerdt, P., Seyfert, U.T. & Hellstern, P. (2005) Variables influencing Platelet Function Analyzer-100TM closure times in healthy individuals. British Journal of Haematology, 130, 759767.
  • Mamiya, S., Hagiwara, M., Inoue, S. & Hidaka, H. (1989) Thyroid hormones inhibit platelet function and myosin light chain kinase. Journal of Biological Chemistry, 264, 85758579.
  • Masunaga, R., Nagasaka, A., Nakai, A., Kotake, M., Sawai, Y., Oda, N., Mokuno, T., Shimazaki, K., Hayakawa, N., Kato, R., Hirano, E., Hagiwara, M. & Hidaka, H. (1997) Alteration of platelet aggregation in patients with thyroid disorders. Metabolism: Clinical and Experimental, 46, 11281131.
  • Myrup, B., Bregengard, C. & Faber, J. (1995) Primary haemostasis in thyroid disease. Journal of Internal Medicine, 238, 5963.
  • Wuillemin, W.A., Gasser, K.M., Zeerleder, S.S. & Lämmle, B. (2002) Evaluation of a Platelet Function Analyser (PFA-100® in patients with a bleeding tendency. Swiss Medical Weekly, 132, 443448.